Despite the holidays, several more states began reporting vaccination data in the past week. The Centers for Disease Control and Prevention (CDC) also made a huge update: this national dashboard is now posting vaccination counts at the state level.
Here are the notable updates:
- I launched a vaccination data page on the CDD site which includes annotations on ten major national sources and every state’s vaccination reporting. I’ll be updating it weekly—the most recent update was yesterday.
- Five states have started regularly reporting vaccination data since December 27: Alabama, Alaska, Indiana, Mississippi, and Wisconsin. 32 total states are now reporting these data; 15 states are reporting race and ethnicity of vaccinated residents. See more details on the resource page.
- On December 30, the CDC started reporting state-level vaccination data on its national COVID-19 dashboard. For every state, the CDC is reporting total vaccine doses distributed and total people who have received their first dose. The dashboard also includes national counts—both for the U.S. as a whole and for long-term care facilities. Data are not yet available for download. According to the most recent update (yesterday, January 2), 4.2 million Americans have received their first dose.
- Drew Armstrong, the Bloomberg reporter who runs the publication’s vaccination dashboard, posted a vaccine data user guide on Twitter. While the Tweet thread primarily describes the methodology and design choices behind Bloomberg’s dashboard, it also provides useful context for vaccination data overall. Two notable details: all vaccination data lag (the CDC’s data lag by about 50 hours, according to Armstrong), and Bloomberg is working on making the underlying data behind their dashboard public.
- Benjy Renton halted updates for the “Doses Administered” tracker on his Vaccine Allocation Dashboard. As the CDC is now providing standardized state counts—and Renton is a one-person tracking operation—he’s switching to focus on analyzing vaccination trends and accessibility.
- Distribution delays: Operation Warp Speed promised that, if the Pfizer and Moderna vaccines received Emergency Use Authorization from the FDA, 20 million Americans would get vaccine doses by the end of 2020. That clearly didn’t happen. What went wrong? To answer that question, I recommend two articles: this STAT News story and this CNN story. Both articles suggest that a lag in data reporting may be one reason why the current vaccination counts look so low. Still, there’s a big difference between 4.2 million and 20 million.
- Vaccination and the new COVID-19 strain: As the B.1.1.7 coronavirus variant, identified in the U.K., becomes an increasingly ominous threat to America’s COVID-19 containment, vaccination becomes increasingly urgent. Zeynep Tufekci’s latest piece in The Atlantic explains the issue. One piece that stuck out to me: the U.S. doesn’t have good genomic surveillance—or, a system to systematically sequence the virus genomes for people infected with SARS-CoV-2—which makes us less equipped to see where the new strain is actually spreading. As Tufekci puts it: “we are flying without a map.”
- One dose or two? Scientists and public health leaders have been debating changing our vaccination protocol. Should the U.S. stick to the script, so to speak, and reserve enough vaccine doses that everyone who receives one dose can receive a second in the prescribed time window? Or should we give as many people first doses as we can, accepting that some may not get a second dose for months—or at all? (The U.K. opted for the latter earlier this week.) University of Washington professor Carl Bergstrom has compiled some Twitter threads that explain the debate. Dr. Fauci said on Friday that the U.S. will stick to the official two-dose regimen, but the scientific discourse will likely continue.
- Sources and updates, February 26Sources and updates for the week of February 26 include deaths in U.S. prisons, the future of COVID-19 vaccines, airplane wastewater testing, and more.
- Sources and updates, February 12Sources and updates for the week of February 12 include routine vaccinations for kids, variant analysis in China, ME/CFS research, and more.
- Sources and updates, February 5Sources and updates for the week of February 5 include modeling persistent COVID-19 risk, global vaccination coverage, COVID-related lawsuits, and more.
- The future of COVID-19 vaccines needs more dataOn Thursday, the FDA’s Vaccines and Related Biological Products Advisory Committee (or VRBPAC) met to discuss the future of COVID-19 vaccines. While the committee readily agreed that our current, Omicron-specific shots are working well and should be used more broadly, it had a hard time answering other questions about future vaccine regimens—largely due to a lack of good data.